Article
Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII delta II.
European journal of biochemistry - 14 Feb 1991
Krishnan S, Kolbe H V, Lepage P, Faure T, Sauerwald R, de la Salle H, Muller C, Bihoreau N, Paolantonacci P, Roitsch C
Abstract excerpt
Factor VIII delta II is a genetically engineered deletion variant of factor VIII expressed by recombinant Chinese hamster ovary cells, in which a major portion of the central (B) domain and a part of the light chain (Pro771-Asp1666) are missing. After immunoaffinity purification, the kinetics of thrombin cleavage of the novel molecule was analysed by SDS/PAGE, Western blotting and N-terminal amino acid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.